Company: DHR
Filing Date: 2025-03-26
Form Type: DEF 14A
Source: 0000313616-25-000081
Chunk: 16

Company: DANAHER CORP /DE/
Filing Date: 2025-03-26
Form: DEF 14A
Chunk 16
---
 C. Stevens, Ph.D.                                                                                                                                                                                                       |     | Principal Responsibilities:                                                                                                                                 |
| •Review and assess the Company’s science and technology innovation strategy and priorities;                                                                                                                                      
 •Assess the competitive position of the Company’s technology portfolio;                                                                                                                                                          
 •Review with management key programs, processes and organizational structures related to innovation, research and development and the commercialization of technology; and                                                       
 •Assess, and advise the Board with respect to, potentially disruptive science and technology trends, opportunities and risks.                                                                                                    |     |                                                                                                                                                             |

Executive Committee

The Executive Committee exercises between meetings of the Board any powers or authority as are specifically delegated to it by the Board from time to time, typically related to business acquisition or capital raising transactions. The Executive Committee did not meet in 2024.

Finance Committee

The Finance Committee approves business acquisitions, investments and divestitures up to the levels of authority delegated to it by the Board. The Finance Committee met twice in 2024.

Board, Committee and Individual Director Evaluations

Our Board recognizes that a rigorous and constructive evaluation process is an essential component of good corporate governance and Board effectiveness. Under the leadership of our Lead Independent Director, the Nominating & Governance Committee oversees the annual evaluation process and periodically reviews the format of the process to help ensure it is eliciting actionable feedback with respect to the effectiveness of the Board, Board committees and individual directors.

The annual Board, committee and individual director evaluation process consists of the following components:

| 2025 Notice of Annual Meeting and Proxy Statement |     | 25 |

| Board & Committee 
 Self-Assessment   |     | Individual Director 
 Self-Assessment     |     | Self-Assessment 
 Meetings        |     | Acting Upon 
 Results     |

Shareholder Engagement and Alignment

Shareholder Engagement Program

General

We actively seek and highly value feedback from our shareholders. During 2024, in addition to our traditional Investor Relations outreach efforts, we engaged with shareholders representing approximately 25% of our outstanding shares on topics including our business strategy and financial performance and our governance, executive compensation and sustainability programs. Attendees included members of our senior management and, in some cases, members of our Board of Directors. We shared feedback received during these meetings with the applicable Board committees, informing their decision-making.

2024 Shareholder Proposals

At Danaher’s 2024 Annual Meeting, our shareholders voted against:

• A shareholder proposal requesting that Danaher amend its governing documents to reduce the percentage of shares required for shareholders to call a special meeting